Skinvisible (SKVI) EPS (Basic) (2016 - 2026)
Skinvisible's EPS (Basic) history spans 16 years, with the latest figure at -$0.05 for Q4 2025.
- On a quarterly basis, EPS (Basic) fell 162.5% to -$0.05 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.2, a 81.82% decrease, with the full-year FY2025 number at -$0.2, down 81.82% from a year prior.
- EPS (Basic) hit -$0.05 in Q4 2025 for Skinvisible, roughly flat from -$0.05 in the prior quarter.
- Over the last five years, EPS (Basic) for SKVI hit a ceiling of $0.08 in Q4 2024 and a floor of -$0.33 in Q1 2023.
- Historically, EPS (Basic) has averaged -$0.07 across 5 years, with a median of -$0.06 in 2021.
- Biggest five-year swings in EPS (Basic): crashed 560.0% in 2023 and later surged 233.33% in 2024.
- Tracing SKVI's EPS (Basic) over 5 years: stood at -$0.04 in 2021, then tumbled by 125.0% to -$0.09 in 2022, then surged by 33.33% to -$0.06 in 2023, then surged by 233.33% to $0.08 in 2024, then tumbled by 162.5% to -$0.05 in 2025.
- Business Quant data shows EPS (Basic) for SKVI at -$0.05 in Q4 2025, -$0.05 in Q3 2025, and -$0.05 in Q2 2025.